Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 18 Sep 2024 – 20 Aug 2026, limited by Axis Consumption Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Consumption Fund | Nifty 500 |
|---|---|---|
| 18 Sep 2024 | ₹100.00 | ₹100.00 |
| 15 Nov 2024 | ₹92.15 | ₹91.90 |
| 13 Jan 2025 | ₹89.97 | ₹88.89 |
| 12 Mar 2025 | ₹83.61 | ₹84.79 |
| 10 May 2025 | ₹88.88 | ₹90.70 |
| 07 Jul 2025 | ₹93.94 | ₹98.55 |
| 04 Sep 2025 | ₹97.91 | ₹95.49 |
| 01 Nov 2025 | ₹97.02 | ₹99.21 |
| 29 Dec 2025 | ₹95.13 | ₹99.09 |
| 26 Feb 2026 | ₹92.25 | ₹98.12 |
| 25 Apr 2026 | ₹87.88 | ₹94.44 |
| 23 Jun 2026 | ₹89.37 | ₹96.29 |
| 20 Aug 2026 | ₹94.44 | ₹98.39 |
| Metric | Axis · Regular NAV ₹9.51 Very High risk ★★☆☆☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| -3.26% | +5.83% | |
| — | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| -2.94% | +12.26% | |
| +2.27% | — | |
| — | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 14.04% | 15.62% | |
| -0.69 | 0.43 | |
| -0.93 | 0.59 | |
| -21.76% | -23.65% | |
| Nifty 500 | — | |
| — | +3.42% | |
| — | 0.95 | |
| — | 105.9% | |
| — | 93.6% | |
| 2.13% | 2.39% | |
| ₹2,796Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹100 | — | |
| 29% | 45% | |
| Krishnaa Narayan | — | |
| 18 Sep 2024 | — | |
| 57 | — | |
| 51.8% | — | |
| -0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.